Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at

Division of AIDS Clinical Research Policies and Standard Procedures Documents

Division of AIDS Policies 

Policies and procedures are essential to any clinical research enterprise. In this regard, the Division of AIDS (DAIDS) has standardized and harmonized operational procedures across research. Accordingly, all human subjects research supported and/or sponsored by NIAID must be compliant with these policies and standard operating procedures in addition to the NIAID Clinical Terms of Award; all National Institutes of Health (NIH) clinical research policies; and 45 CFR 46, subparts B-D. These documents also serve as resources for DAIDS collaborators and staff to refer for division requirements on the conduct of DAIDS research.

The applicability of each policy and standard operating procedure to different types of human subject research (i.e., clinical research, observational research, or clinical trials) is outlined in the document’s statement of Scope.

DAIDS expects compliance with all applicable policies and procedures within 30 days of the “effective date” stated on each document. DAIDS may, at its discretion, request the Clinical Site Monitoring Group (CSMG) monitors to spot-check documentation for compliance to these policies and standard operating procedures during monitoring visits.

Content last reviewed on December 14, 2017